Shares of Moderna jumped before paring their gains Wednesday after analysts said a $1.5 billion coronavirus vaccine supply agreement with the U.S. government could lead to similar deals with other countries.
Fred Katayama reports.
Shares of Moderna jumped before paring their gains Wednesday after analysts said a $1.5 billion coronavirus vaccine supply agreement with the U.S. government could lead to similar deals with other countries.
Fred Katayama reports.
Moderna will supply 40 million doses of its Covid-19 vaccine to Japan, another sign of how countries are stockpiling vaccines even..
The Trump Administration has reached a $1.5B deal with Moderna Inc, the company working on a COVID-19 vaccine.